Comments on: Codexis IPO is Long on Promise – and Risk http://gigaom.com/2008/04/15/codexis-ipo-is-long-on-promise-and-risk/ Thu, 20 Jun 2013 07:25:39 +0000 hourly 1 http://wordpress.com/ By: Codexis IPO: Biocatalyst Startup Debuts on Nasdaq at Low End http://gigaom.com/2008/04/15/codexis-ipo-is-long-on-promise-and-risk/#comment-11321 Thu, 22 Apr 2010 21:51:13 +0000 http://earth2tech.com/?p=1875#comment-11321 [...] then searches for the variants best suited to development of new, potentially cheaper drugs (Pfizer used Codexis enzymes to produce Lipitor), fuel from cellulosic biomass, chemicals and systems for water treatment and carbon [...]

]]> By: Codexis Files for IPO, Again http://gigaom.com/2008/04/15/codexis-ipo-is-long-on-promise-and-risk/#comment-11320 Tue, 29 Dec 2009 00:53:11 +0000 http://earth2tech.com/?p=1875#comment-11320 [...] then searches for the variants best suited to the development of new, potentially cheaper drugs (Pfizer used Codexis enzymes to produce Lipitor) and non-ethanol [...]

]]> By: Codexis Aims to Bridge Biotech and Carbon Capture http://gigaom.com/2008/04/15/codexis-ipo-is-long-on-promise-and-risk/#comment-11319 Wed, 16 Dec 2009 15:29:59 +0000 http://earth2tech.com/?p=1875#comment-11319 [...] then searches for the variants best suited to development of new, potentially cheaper drugs (Pfizer used Codexis enzymes to produce Lipitor) and non-ethanol biofuels. This summer, the 7-year-old startup said it was looking for ways to [...]

]]>